RE:It amazes mewoundedknee wrote: Why TLT is still hanging on to their money losing cold laser division. Is there one shareholder (major, insider, or retail) who actually bought TLT stock because of cold laser? cheers.
P.S. As a past shareholder who always keeps an eye on this company, is Bencro, the yellow marker kid, who only cares about the science, or his new handle still posting?
I think the laser tech that they developed fot their current lineup of therapeutic lasers proved critical in the development of their NMIBC dosemetry device. So I think it is worth it to keep the 'division' around for that, as the odd cancer indication might need an advanced dosemetry device/laser.
More importantly for their ACT is the CLT cancer pre-treatment piece they developed using their lasers, that alone is probably worth 1 $Bill US.
:-)